Pharvaris N.V. PHVS
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 50.30% | 5.79% | -13.57% | -13.57% | 0.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.92% | 15.28% | 11.29% | 11.29% | 23.82% |
| Operating Income | -28.92% | -15.28% | -11.29% | -11.29% | -23.82% |
| Income Before Tax | -6.92% | -46.85% | 4.33% | 4.33% | -60.96% |
| Income Tax Expenses | 204.39% | 46.64% | -183.87% | -183.87% | 202.76% |
| Earnings from Continuing Operations | -7.80% | -46.84% | 5.32% | 5.32% | -61.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.80% | -46.84% | 5.32% | 5.32% | -61.30% |
| EBIT | -28.92% | -15.28% | -11.29% | -11.29% | -23.82% |
| EBITDA | -29.13% | -15.25% | -11.28% | -11.28% | -23.56% |
| EPS Basic | 13.39% | -22.49% | 17.77% | 17.77% | -59.08% |
| Normalized Basic EPS | 14.10% | -22.50% | 16.90% | 16.90% | -58.77% |
| EPS Diluted | 13.39% | -22.49% | 17.77% | 17.77% | -59.08% |
| Normalized Diluted EPS | 14.10% | -22.50% | 16.90% | 16.90% | -58.77% |
| Average Basic Shares Outstanding | 24.47% | 19.88% | 15.14% | 15.14% | 1.39% |
| Average Diluted Shares Outstanding | 24.47% | 19.88% | 15.14% | 15.14% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |